Observational study finds insomnia and sleep apnea increase cardiovascular disease risk in veterans — Evidence Review
Published in Journal of the American Heart Association, by researchers from Yale School of Medicine
Researched by
— the AI search engine for science
Table of Contents
Adults with both insomnia and obstructive sleep apnea face a much higher risk of cardiovascular disease, and a large study of U.S. veterans suggests that assessing and treating both sleep disorders together may help prevent heart problems. The main findings from this research align closely with prior studies, which consistently link sleep disturbances—especially when combined—to increased cardiovascular risk, as also seen in related literature referenced in the Journal of the American Heart Association.
- Studies consistently show that both insomnia and obstructive sleep apnea independently increase cardiovascular risk, and their combination (COMISA) is linked to even higher rates of hypertension, heart disease, and mortality 1 2 3 4 6.
- Prior research has found that sleep disturbances are modifiable risk factors for cardiovascular outcomes, but management typically treats sleep disorders in isolation rather than in combination, potentially missing the cumulative risk 3 4 11.
- There is strong evidence that improving sleep health—by addressing both sleep apnea and insomnia—may have a substantial preventive impact on cardiovascular disease, supporting the new study’s call for early identification and integrated management of sleep disorders 7 9 11.
Study Overview and Key Findings
Cardiovascular disease remains the leading cause of death worldwide, and sleep health is increasingly recognized as a modifiable risk factor. This new study addresses an important gap by focusing on the joint impact of insomnia and obstructive sleep apnea—two common sleep disorders that frequently co-occur but are often managed separately. By analyzing data from nearly 1 million post-9/11 U.S. veterans, the study provides large-scale evidence that the combination of insomnia and sleep apnea (referred to as COMISA) is a particularly harmful risk factor for early development of high blood pressure and cardiovascular disease, with implications for prevention strategies.
| Property | Value |
|---|---|
| Organization | Yale School of Medicine |
| Journal Name | Journal of the American Heart Association |
| Authors | Allison Gaffey, Andrey Zinchuk |
| Population | Post-9/11 U.S. veterans |
| Sample Size | nearly 1 million |
| Methods | Observational Study |
| Outcome | Cardiovascular disease risk, high blood pressure |
| Results | COMISA significantly raises cardiovascular disease risk. |
Literature Review: Related Studies
To place these findings in context, we searched the Consensus paper database, which contains over 200 million research papers. The following search queries were used to identify relevant studies:
- insomnia sleep apnea heart disease risk
- cardiovascular disease insomnia sleep studies
- sleep disorders cardiovascular health outcomes
Related Studies: Key Topics and Findings
| Topic | Key Findings |
|---|---|
| How do insomnia and sleep apnea individually and jointly affect cardiovascular risk? | - Both insomnia and obstructive sleep apnea are independently associated with increased risk of hypertension and cardiovascular disease; their combination (COMISA) further amplifies this risk 1 2 3 4 6. - COMISA is linked to higher rates of mortality and heart disease than either disorder alone 3 4. |
| Can improving sleep health reduce cardiovascular risk, and how is sleep health best measured? | - Healthy sleep patterns, including regular duration and timing, are associated with reduced risks of cardiovascular disease, even among those at high genetic risk 7 9. - Incorporating sleep quality, insomnia, and sleep apnea into cardiovascular health scores increases predictive value for CVD risk 11. |
| What mechanisms link sleep disturbances to cardiovascular disease? | - Insomnia and sleep apnea may increase cardiovascular risk via heightened sympathetic nervous system activity, inflammation, and hormonal changes 2 5 13. - Repeated disruptions of normal sleep architecture impair the heart’s recovery and adaptation capacity 5 12 13. |
| Who is most at risk, and what is the prevalence of comorbid insomnia and sleep apnea? | - COMISA affects nearly 30% of patients with sleep apnea and is associated with higher rates of hypertension, heart disease, and reduced quality of life 4. - Sleep problems may confer greater cardiovascular risk in populations under 60 years and may interact with other risk factors such as obesity and diabetes 1 14. |
How do insomnia and sleep apnea individually and jointly affect cardiovascular risk?
Related studies strongly support the new study’s findings: both insomnia and obstructive sleep apnea (OSA) are independent risk factors for cardiovascular disease, and their combination—COMISA—poses greater risk than either disorder alone. Several large-scale observational studies and meta-analyses demonstrate increased rates of hypertension, heart disease, and mortality in those with comorbid insomnia and OSA 1 2 3 4 6. The new study adds large-scale, U.S. veteran-specific data to this body of evidence and emphasizes the need for integrated assessment and management.
- Both insomnia and OSA are independently associated with increased risk of hypertension, coronary heart disease, and heart failure 1 2 6.
- COMISA is linked to a 47% increased risk of all-cause mortality and higher rates of cardiovascular disease compared to those with neither condition or with only one disorder 3 4.
- The prevalence of COMISA is substantial, found in approximately 29% of patients with OSA 4.
- Prior studies suggest that treating only one of the disorders may not sufficiently reduce cardiovascular risk, highlighting the importance of combined assessment 3 4.
Can improving sleep health reduce cardiovascular risk, and how is sleep health best measured?
A growing body of literature indicates that healthy sleep—defined by regular duration, timing, and absence of sleep disorders—may contribute to lower cardiovascular risk, even in individuals with genetic predisposition. The inclusion of sleep metrics in cardiovascular health assessments has been shown to improve risk prediction. The new study’s focus on prevention and early intervention aligns with calls to integrate sleep assessment into cardiovascular risk screening protocols.
- A healthy sleep pattern is associated with up to 35% lower risk of cardiovascular disease, with nearly 10% of cardiovascular events attributable to poor sleep 7.
- Sleep regularity (consistent sleep duration and timing) independently predicts cardiovascular events, even after adjusting for traditional risk factors 9.
- Adding sleep health to cardiovascular health scores increases predictive value for incident cardiovascular disease and may improve prevention 11.
- Early identification and management of sleep disorders could shift the focus from treating established disease to prevention 7 11.
What mechanisms link sleep disturbances to cardiovascular disease?
Research has identified several physiological pathways by which insomnia and sleep apnea may contribute to cardiovascular disease. These include activation of the sympathetic nervous system, hormonal dysregulation, inflammation, and impaired nocturnal cardiovascular recovery. The new study’s findings are consistent with the mechanistic understanding that disrupted sleep impairs the body's ability to reset cardiovascular function nightly.
- Insomnia and sleep loss can elevate cortisol, increase sympathetic activity, and promote inflammation, all of which contribute to hypertension and heart disease 2 5 13.
- Sleep apnea leads to intermittent hypoxia, oxidative stress, and hemodynamic changes that stress the heart and vasculature 5 12.
- Nightly disruptions in sleep architecture reduce the heart’s opportunity for rest and repair, increasing long-term cardiovascular risk 5 13.
- Subtypes of OSA may differ in their impact on cardiovascular outcomes, suggesting a need for individualized approaches 12.
Who is most at risk, and what is the prevalence of comorbid insomnia and sleep apnea?
Prevalence data indicate that comorbid insomnia with OSA is common, affecting nearly one-third of OSA patients. Certain populations—such as veterans, individuals under 60, and those with existing metabolic risk factors—may face higher risk of sleep-related cardiovascular disease. The new study’s focus on veterans underscores the importance of targeted interventions in high-risk groups.
- COMISA affects about 29% of OSA patients and is associated with higher rates of hypertension, heart disease, and lower quality of life 4.
- Sleep problems confer greater cardiovascular risk in people younger than 60 and may interact with other risk factors like obesity, diabetes, and hypertension 1 14.
- Females with OSA and insomnia may have distinct risk profiles for cardiovascular events 4 14.
- The burden of sleep disorders is particularly high in certain populations, such as veterans, making early screening and intervention crucial 4 14.
Future Research Questions
Although substantial evidence links insomnia, sleep apnea, and COMISA to increased cardiovascular risk, key questions remain. Future research should address causality, intervention effectiveness, and optimal strategies for integrating sleep assessment into cardiovascular care. Additional studies are needed to determine how best to prevent and treat COMISA, and to clarify which patient populations benefit most from targeted interventions.
| Research Question | Relevance |
|---|---|
| Does treating both insomnia and sleep apnea reduce cardiovascular disease risk more than treating one alone? | Understanding the additive or synergistic benefit of combined treatment is essential for developing effective prevention strategies for high-risk patients 3 4 10. |
| What are the most effective screening tools for identifying COMISA in primary care settings? | Early detection of COMISA could enable timely intervention, but practical and validated screening tools are needed for widespread implementation 4 11. |
| How do biological mechanisms differ between COMISA and isolated sleep disorders in contributing to cardiovascular disease? | Elucidating distinct pathophysiological pathways could inform targeted therapies and risk stratification for patients with different sleep disorder profiles 2 12. |
| What population subgroups are most vulnerable to the cardiovascular impacts of COMISA? | Identifying high-risk groups (e.g., by age, sex, comorbidities, or genetic profile) will help tailor prevention and intervention efforts 4 7 14. |
| Does early screening and intervention for sleep disorders in young adults prevent cardiovascular disease development? | Preventing cardiovascular disease by addressing sleep problems early could have significant public health benefits, but evidence from prospective trials is needed 7 14. |
In summary, robust evidence indicates that addressing both insomnia and sleep apnea may be critical for the prevention of cardiovascular disease. The integration of sleep health into routine cardiovascular risk assessment and early intervention strategies represents a promising direction for research and clinical care.